Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Wow. Share price is going to be negative soon. I think I owe Geremy money now.......but I support Goodbody Marc......
They will probably move into something like weight management next. Would fit in well.
I don't have a crawler script. I am just bloody nosey :). I am feeling alot more optimistic about the way this is going. Not so much clinics any more. More like outlets with free standing units. Either way they are connecting with the masses...
The clinics are coming on line at a pace now. 190 listed. Marc had spoken about an exciting strategy for future growth......interesting comments
I think it is really good. Addresses all issues. There is clearly more in the pipeline. I would love to know what our cash reserves are. November newsletter will be interesting.
https://www.bbc.co.uk/news/health-63331805?at_medium=RSS&at_campaign=KARANGA
Also who was in the room? Serious investors?
From a consumer point of view, it looks good on the presentation. From an investor point of view, I am not so sure. Geremy's ultimate aim will be build up enough strength in the business to sell it on. That could be years away. I believe when the offer comes in for the business though it will be significant.
However, there were some real positives in there. Subscriptions, talking to insurance companies and not needing cash from anyone to progress further. Like the sound of all of that.
One drawback to the plan is the fact researchers are calling on five million UK adults to take part in one of the biggest studies in the world. Part of the study is to have blood tests for blood sugar levels, cholesterol and genetic testing. This is being funded by government money, industry and charities. If we are in on this then that great, if not, then a large section of the market has already been accessed for these tests.
Disgraceful. No trades but the bid has dropped again.
You would think that they would announce that. I love the idea of the free standing units. They could expand nationally very quickly with those. Very good approach to quick wins.
Wow.....quite a big jump in the clinic numbers. Up to 177 now. Good to see after such a slow down. Its clearly working for them.
Does that make the market cap £2m? They will take that the 3rd quarter alone.
Hell of a spread at the minute.
Recent Share Trades for Goodbody Health Limited (GDBY.PL)
Date Time Trade Prc Volume Buy/Sell Value
22-Sep-22 15:22:07 10.01 9 Sell* 0.90 O
22-Sep-22 15:12:48 10.10 13 Sell* 1.31 O
22-Sep-22 15:05:46 10.10 342 Sell* 34.54 O
22-Sep-22 14:56:31 10.10 2 Sell* 0.20 O
22-Sep-22 14:46:37 10.10 387 Sell* 39.09
What's this about?
We had the perfect opportunity to ask as many questions as we liked. Marc answered the questions put to him. I thought that this was brilliant on their behalf. We have added more clinics recently. (First time in a while) I can see 151 now. We are also talking directly to GP surgeries about initial blood testing on their behalf. This is so good because we are going to the patient instead of waiting for the patient to come to us. The ear wax treatment is another great example of diversification. They are building the numbers but we just cannot see them yet. I think at this stage they know what they are doing, what works and what does not. We are still looking at years rather than months for any great returns. Unless of course someone buys us out.
What is the price that shows 0.35usd? Don't understand that. I thought we were only trading in the UK now.
Some trades going through today. We have some movement.
Goodbody Health’s Howells cheers ‘new era’ as cancer testing increasingly catches disease earlier.
Goodbody Health Ltd - Goodbody Health’s Howells cheers ‘new era’ as cancer testing increasingly catches disease earlier
Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) chief executive Marc Howells has cheered a new era in which blood testing is increasingly detecting the presence of cancer cells early, allowing earlier diagnosis that can help save lives.
The UK-listed health, wellness and diagnostics firm is presently working to expand its businesses after a period in which COVID testing had dominated its operational attention and revenues during the pandemic years.
Goodbody in June announced to investors plans to launch new genetic tests to help people understand their risk of cancer and heart disease.
These testing products, known as polygenetic tests, are being delivered in conjunction with Goodbody’s partner Everything Genetic, and, add to the company’s portfolio of wellness tests that help customers “know more, live better”.
“We support the continual progression of blood testing, and a great example is shown with our hereditary cancer genetic tests which check your risk of developing the same cancer as your parents,” Howells said.
Howells comments come in the wake of a key breakthrough for what’s described as a potential game-changing blood test, known as the Galleri test, which looks for cancer DNA in the blood and has now been validated by a study of 6,600 adults aged over 50. According to reports, the study detected dozens of new cancer cases before the subjects had shown any symptoms of the disease.
It was the first result assessing the effectiveness of the Galleri test, before a much larger NHS study involving some 165,000 people report results in 2023.
Howell described the breakthrough of the Galleri test, developed by California health tech firm GRAIL, as “a great stop forward”.
“We are in a new era where blood tests are increasingly helping people identify multiple cancer types before they have developed symptoms with the hope that early detection can save more lives,” Howells said.
Goodbody Health in June told investors that its plan to roll-out genetic cancer testing services aims to help focus on prevention and early detection, whilst helping alleviate the pressures on the NHS in line with the NHS long term plan.
It highlighted, at that time, Cancer Research UK data which says that 38% of cancer cases are preventable and that 50% of people will survive cancer for 10 or more years.
Goodbody’s initially made available 4 tests, which test saliva samples and can provide results within around 4 weeks.
They comprise a ‘female polygenic risk score genetic cancer test’, a ‘male polygenic risk score genetic cancer test’, a ‘polygenic risk score test + full gene cancer genetic test.
If they prove the model works with GPs we will take off in a massive way tho. The numbers would be staggering. The updates has been helpful in keeping the faith.